Your browser doesn't support javascript.
loading
Erythroblastic synartesis associated with lymphoproliferative disorder: There can be more than meets the eye.
Mettler, Camille; Petit, Cassandre; Ernest, Vincent; Asli, Bouchra; Daniel, Marie-Thérèse; Mathis, Stéphanie; Zini, Jean Marc; Faucher, Benoit; Ebbo, Mikael; Legendre, Paul; Malphettes, Marion.
Afiliación
  • Mettler C; Timone Hospital, Internal Medicine Department, AP-HM, Marseille, France. Electronic address: camille.mettler@ap-hm.fr.
  • Petit C; Timone Hospital, Internal Medicine Department, AP-HM, Marseille, France.
  • Ernest V; Timone Hospital, Internal Medicine Department, AP-HM, Marseille, France.
  • Asli B; Sauvegarde Clinic, Internal Medicine Department, Lyon, France.
  • Daniel MT; Saint-Louis Hospital, Hematology Laboratory, AP-HP, Paris, France.
  • Mathis S; Saint-Louis Hospital, Hematology Laboratory, AP-HP, Paris, France.
  • Zini JM; Saint-Louis Hospital, Immuno-Hematology Department, AP-HP, Paris, France.
  • Faucher B; Timone Hospital, Internal Medicine Department, AP-HM, Marseille, France.
  • Ebbo M; Timone Hospital, Internal Medicine Department, AP-HM, Marseille, France.
  • Legendre P; Foch Hospital, Internal Medicine Department, Suresnes, France.
  • Malphettes M; Saint-Louis Hospital, Immuno-Hematology Department, AP-HP, Paris, France.
Clin Immunol ; 236: 108951, 2022 03.
Article en En | MEDLINE | ID: mdl-35134549
ABSTRACT
Erythroblastic synartesis is a rare cause of acquired dyserythropoiesis. Only 9 cases have been previously reported. We hereby report 3 cases of patients diagnosed with erythroblastic synartesis associated with monoclonal immunoglobulin and an overt malignant lymphoid disorder. A different B-cell clone may produce the monoclonal immunoglobulin, forming a biclonal disorder. In light of these data and literature review, treatment targeting the paraprotein seems to be efficient to control synartesis and correct anemia. In the case of monoclonal gammapathy associated with chronic lymphocytic leukemia, therapeutics should be adapted to control both chronic lymphocytic leukemia and monitored monoclonal immunoglobulin titer.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Paraproteinemias / Leucemia Linfocítica Crónica de Células B / Trastornos Linfoproliferativos Tipo de estudio: Risk_factors_studies Límite: Humans Idioma: En Revista: Clin Immunol Asunto de la revista: ALERGIA E IMUNOLOGIA Año: 2022 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Paraproteinemias / Leucemia Linfocítica Crónica de Células B / Trastornos Linfoproliferativos Tipo de estudio: Risk_factors_studies Límite: Humans Idioma: En Revista: Clin Immunol Asunto de la revista: ALERGIA E IMUNOLOGIA Año: 2022 Tipo del documento: Article